{"organizations": [], "uuid": "6561cd826c3c1957e86d9034ae7fd158a7ee0700", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-ra-pharmaceuticals-announces-prese/brief-ra-pharmaceuticals-announces-presentation-of-ra101495-sc-phase-2-gmg-clinical-trial-design-at-70th-annual-aan-meeting-idUSASC09X98", "country": "US", "domain_rank": 408, "title": "BRIEF-Ra Pharmaceuticals Announces Presentation Of RA101495 SC Phase 2 gMG Clinical Trial Design At 70Th Annual AAN Meeting", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-25T14:17:00.000+03:00", "replies_count": 0, "uuid": "6561cd826c3c1957e86d9034ae7fd158a7ee0700"}, "author": "", "url": "https://www.reuters.com/article/brief-ra-pharmaceuticals-announces-prese/brief-ra-pharmaceuticals-announces-presentation-of-ra101495-sc-phase-2-gmg-clinical-trial-design-at-70th-annual-aan-meeting-idUSASC09X98", "ord_in_thread": 0, "title": "BRIEF-Ra Pharmaceuticals Announces Presentation Of RA101495 SC Phase 2 gMG Clinical Trial Design At 70Th Annual AAN Meeting", "locations": [], "entities": {"persons": [{"name": "pha", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "aan meeting reuters staff", "sentiment": "none"}, {"name": "min read    ra pharmaceuticals inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 25 (Reuters) - Ra Pharmaceuticals Inc:\n* RA PHARMACEUTICALS ANNOUNCES PRESENTATION OF RA101495 SC PHASE 2 GMG CLINICAL TRIAL DESIGN AT THE 70TH ANNUAL AAN MEETING\n* RA PHARMACEUTICALS INC - REMAINS ON TRACK TO REPORT DATA FROM RA101495 SC PHASE 2 GMG STUDY IN FIRST HALF OF 2019 Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-04-25T14:17:00.000+03:00", "crawled": "2018-04-25T14:30:22.003+03:00", "highlightTitle": ""}